Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-25 @ 1:27 AM
NCT ID: NCT02330094
Eligibility Criteria: Inclusion Criteria: 1. 18 years of age or older 2. Have aneurysmal subarachnoid hemorrhage (aSAH) diagnosed by CT scan of the brain and/or angiogram evidence of intracranial aneurysm (CTA or digital subtraction angiogram or MRA) 3. Have symptomatic headache 4. Able to swallow and verbalize pain score 5. No known allergy to gabapentin or fentanyl 6. Numeric pain score ≥ 5 7. Ability to provide written personal consent Exclusion Criteria: 1. Gabapentin use prior to SAH admission 2. Renal failure with creatinine clearance less than 30 mL/min 3. Unable to receive standard of care pain medications 4. Pregnant or breastfeeding patients 5. History of severe depression defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM IV)
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT02330094
Study Brief:
Protocol Section: NCT02330094